Related Experiment Videos
A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic
Michael Eldar1, Elon Pras, Hadas Lahat
1Heart Institute, Sheba Medical Center, Tel Hashomer, Israel. meldar@post.tau.ac.il
Abstract:
Catecholamine-induced polymorphic ventricular tachycardia (CPVT), a rare disease that occurs in subjects without obvious organic heart disease, is characterized by episodes of syncope, seizures, or sudden death in response to physiologic or emotional stress. This report reviews evidence that a missense mutation in the CASQ2 gene is associated with autosomal-recessive CPVT.
Insights
Catecholamine-induced polymorphic ventricular tachycardia (CPVT) is a rare heart condition. Evidence links a CASQ2 gene mutation to the autosomal-recessive form of CPVT.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Catecholamine-induced polymorphic ventricular tachycardia (CPVT) is a rare genetic disorder.
- CPVT presents without apparent structural heart disease, triggered by stress.
- Symptoms include syncope, seizures, and sudden cardiac death.
Purpose of the Study:
- To review evidence associating CASQ2 gene mutations with CPVT.
- To explore the genetic underpinnings of autosomal-recessive CPVT.
Main Methods:
- Literature review of genetic studies on CPVT.
- Analysis of evidence linking CASQ2 gene variants to CPVT phenotypes.
Main Results:
- A specific missense mutation in the CASQ2 gene is identified as a cause of CPVT.
- This mutation is associated with the autosomal-recessive inheritance pattern of the disease.
Conclusions:
- The CASQ2 gene plays a critical role in the pathogenesis of autosomal-recessive CPVT.
- Genetic testing for CASQ2 mutations can aid in diagnosing CPVT.